Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1983-7-29
|
| pubmed:abstractText |
One hundred and sixty-one female patients, over the age of 70, with breast cancer were treated by Tamoxifen alone in a pilot phase II study. 61% showed objective regression of the disease and in 27% there was complete remission. The treatment was well tolerated and the survival rate compared favourably to that following conventional methods of treatment. An accurate assessment of the method awaits a randomized clinical trial.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0305-7399
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
31-4
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:6851305-Age Factors,
pubmed-meshheading:6851305-Aged,
pubmed-meshheading:6851305-Breast Neoplasms,
pubmed-meshheading:6851305-Drug Evaluation,
pubmed-meshheading:6851305-Female,
pubmed-meshheading:6851305-Humans,
pubmed-meshheading:6851305-Neoplasm Recurrence, Local,
pubmed-meshheading:6851305-Tamoxifen
|
| pubmed:year |
1983
|
| pubmed:articleTitle |
Primary treatment of breast cancer in elderly women with Tamoxifen.
|
| pubmed:publicationType |
Journal Article
|